Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2024
About
Suggestions
Contact Us
Rifaximin
MeSH Descriptor Data 2025
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Rifaximin
Tree Number(s)
D03.633.400.811.850
D04.345.295.750.850
Unique ID
D000078262
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000078262
Scope Note
A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of
GASTROENTERITIS
caused by
ESCHERICHIA COLI INFECTIONS
. It may also be used in the treatment of
HEPATIC ENCEPHALOPATHY
.
Entry Term(s)
4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin
L 105
L-105
Redactiv
Xifaxan
Pharm Action
Anti-Bacterial Agents
Gastrointestinal Agents
Registry Numbers
L36O5T016N
0
CAS Type 1 Name
2,7-(Epoxy(1,11,13)pentadecatrienoimino)furo(2'',3'':7',8')naphth(1',2':4,5)imidazo(1,2-a)pyridine-1,15(2H)-dione, 25-(acetyloxy)-5,6,21,23-tetrahydroxy-27-methoxy-2,4,11,16,20,22,24,26-octamethyl-, ( 2S,16Z,18E,20S,21S,22R,23R,24R,25S,26R,27S,28E)-
Public MeSH Note
2019; RIFAXIMIN was indexed under RIFAMYCINS 1983-2018
History Note
2019 (1983)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/05/21
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analogs & derivatives (AA)
analysis (AN)
antagonists & inhibitors (AI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Heterocyclic Compounds [D03]
Heterocyclic Compounds, Fused-Ring [D03.633]
Heterocyclic Compounds, 4 or More Rings [D03.633.400]
Rifamycins [D03.633.400.811]
Rifabutin [D03.633.400.811.650]
Rifampin [D03.633.400.811.700]
Rifaximin [D03.633.400.811.850]
Polycyclic Compounds [D04]
Macrocyclic Compounds [D04.345]
Lactams, Macrocyclic [D04.345.295]
Rifamycins [D04.345.295.750]
Rifabutin [D04.345.295.750.650]
Rifampin [D04.345.295.750.700]
Rifaximin [D04.345.295.750.850]
Expand All
Collapse All
Rifaximin
Preferred
Concept UI
M0126046
Registry Numbers
L36O5T016N
Scope Note
A synthetic rifamycin derivative and anti-bacterial agent that is used for the treatment of
GASTROENTERITIS
caused by
ESCHERICHIA COLI INFECTIONS
. It may also be used in the treatment of
HEPATIC ENCEPHALOPATHY
.
Terms
Rifaximin
Preferred Term
Term UI
T000942166
Date
04/17/2018
LexicalTag
NON
ThesaurusID
4-Deoxy-4'-methylpyrido(1',2'-1,2)imidazo(5,4C)rifamycin
Term UI
T000942167
Date
04/17/2018
LexicalTag
NON
ThesaurusID
NLM (1983)
L 105
Narrower
Concept UI
M0126044
Registry Numbers
0
Terms
L 105
Preferred Term
Term UI
T156049
Date
01/01/1955
LexicalTag
LAB
ThesaurusID
NLM (1983)
L-105
Term UI
T156050
Date
01/01/1955
LexicalTag
LAB
ThesaurusID
Redactiv
Narrower
Concept UI
M0475049
Registry Numbers
0
Terms
Redactiv
Preferred Term
Term UI
T616905
Date
11/02/2004
LexicalTag
TRD
ThesaurusID
MX
Xifaxan
Narrower
Concept UI
M0492450
Registry Numbers
0
Terms
Xifaxan
Preferred Term
Term UI
T641046
Date
05/19/2005
LexicalTag
TRD
ThesaurusID
page delivered in 0.162s